Pfizer-BioNTech Omicron retooled booster authorised in Canada
Regulators in the European Union and Japan have also cleared Pfizer's updated booster shot.
Advertisement
Canada: Canada on Friday authorised updated COVID-19 booster shots from Pfizer Inc and its partner BioNTech SE that target the Omicron BA.4 and BA.5 subvariants, according to the government's website.
Pfizer and BioNTech said in a joint statement the companies will make "significant volumes of the vaccine available in the coming days".
The booster shot, which has been authorised for people 12 years and older, is the second to get clearance from Health Canada after Moderna Inc's modified booster last month.
Moderna's vaccine booster was cleared for use in adults.
The so-called bivalent vaccines target both the original variant as well as the two Omicron subvariants.
Pfizer, which is seeking approval from U.S. and European health regulators for use of its Omicron-tailored shot in children 5 through 11 years of age, said it was planning a submission to Health Canada for the same age group.
The U.S. Food and Drug Administration authorised updated COVID-19 booster shots from both Moderna and Pfizer/BioNtech in August.
Regulators in the European Union and Japan have also cleared Pfizer's updated booster shot.
Read also: Pfizer COVID vaccine clears Japan panel for use with young children
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.